Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part D Success Enhances Pharma’s Political Effectiveness, Execs Predict

This article was originally published in The Pink Sheet Daily

Executive Summary

Industry gained enhanced bargaining position and improved image - advantages in future health care reform debates, Merck’s Clark and Schering-Plough’s Hassan say.
Advertisement

Related Content

Medicare Drug Price Debate May Reemerge After Election, BIO Fears
Medicare Drug Price Debate May Reemerge After Election, BIO Fears
Medicare Part D Rebates Will Top 9 Percent Of Drug Costs, Medicare Trustees Project
Medicare Part D Rebates Will Top 9 Percent Of Drug Costs, Medicare Trustees Project

Topics

Advertisement
UsernamePublicRestriction

Register

PS066742

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel